|
| | Vindesine sulfate Basic information |
| Product Name: | Vindesine sulfate | | Synonyms: | Desacetylvinblastine amide sulfate salt;Fildesi;LY-099094;VINCRISITINESULFATE;Vincaleukoblastine, 3-(aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)-, sulfate (1:1) (salt);VINDESINE SULFATE SALT;Methyl (1S,13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbaMoyl-12-ethyl-10,11-dihydroxy-5-Methoxy-8-Methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2(7),3,5,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.0^{4,12}.;Elsedine | | CAS: | 59917-39-4 | | MF: | C43H57N5O11S | | MW: | 852 | | EINECS: | 261-984-7 | | Product Categories: | Anti-cancer & immunity;Intermediates & Fine Chemicals;Pharmaceuticals;APIs | | Mol File: | 59917-39-4.mol |  |
| | Vindesine sulfate Chemical Properties |
| Melting point | >2500C | | storage temp. | 2-8°C | | solubility | deionized water: ≥50mg/mL | | form | powder | | color | off-white to light yellow | | Stability: | Hygroscopic |
| Hazard Codes | Xn | | Risk Statements | 40 | | Safety Statements | 26-36 | | RIDADR | 1544 | | WGK Germany | 3 | | RTECS | YY8090000 | | HazardClass | 6.1(a) | | PackingGroup | II | | Toxicity | LD50 in mice, rats (mg/kg): 6.3 ± 0.6, 2.0 ± 0.2 i.v. (Todd); in mice: 8.8 ± 2.5 i.p. (Owellen, Biochem. Pharmacol.) |
| | Vindesine sulfate Usage And Synthesis |
| Chemical Properties | Amorphous Solid | | Uses | anticancer | | Uses | Vindesine Sulfate Salt is a synthetic derivative of the dimeric Catharanthus alkaloid vinblastine. Antineoplastic. | | Definition | ChEBI: Vindesine sulfate is an alkaloid sulfate salt. It has a role as an antineoplastic agent. It is functionally related to a vindesine. | | Brand name | Eldisine (Lilly). |
| | Vindesine sulfate Preparation Products And Raw materials |
|
